SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891020-05-000024
Filing Date
2005-02-01
Accepted
2005-02-01 17:16:26
Documents
9
Period of Report
2005-01-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v05111e8vk.htm 8-K 22593
2 EXHIBIT 3.1 v05111exv3w1.txt EX-3.1 43913
3 EXHIBIT 3.2 v05111exv3w2.txt EX-3.2 101562
4 EXHIBIT 10.1 v05111exv10w1.txt EX-10.1 31127
5 EXHIBIT 10.2 v05111exv10w2.txt EX-10.2 26317
6 EXHIBIT 10.3 v05111exv10w3.txt EX-10.3 9622
7 EXHIBIT 10.4 v05111exv10w4.txt EX-10.4 4720
8 EXHIBIT 10.5 v05111exv10w5.txt EX-10.5 2862
9 EXHIBIT 99.1 v05111exv99w1.txt EX-99.1 4874
  Complete submission text file 0000891020-05-000024.txt   250367
Mailing Address
Business Address 21720-23RD DRIVE SE, SUITE 100 BOTHELL WA 98021 4256083000
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-33393 | Film No.: 05566621
SIC: 2834 Pharmaceutical Preparations